Osaic Holdings
MDNA

Osaic Holdings’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Osaic Holdings’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-22,000
Closed -$6.49K – 7596
2023
Q3 		$6.49K Sell
22,000
-176
-0.8% -$68 ﹤0.01% 6147
2023
Q2 		$10.7K Hold
22,176
– – ﹤0.01% 5919
2023
Q1 		$14K Hold
22,176
– – ﹤0.01% 5781
2022
Q4 		$10K Hold
22,176
– – ﹤0.01% 5958
2022
Q3 		$18K Hold
22,176
– – ﹤0.01% 5677
2022
Q2 		$25K Hold
22,176
– – ﹤0.01% 5474
2022
Q1 		$96K Buy
22,176
+500
+2% +$776 ﹤0.01% 4626
2021
Q4 		$35K Buy
21,676
+2,000
+10% +$4.15K ﹤0.01% 5420
2021
Q3 		$54K Buy
19,676
+17,000
+635% +$42.1K ﹤0.01% 5047
2021
Q2 		$9K Buy
2,676
+500
+23% +$1.85K ﹤0.01% 6159
2021
Q1 		$9K Buy
2,176
+2,000
+1,136% +$8.14K ﹤0.01% 5954
2020
Q4 		$1K Buy
+176
New +$709 ﹤0.01% 6313

Other funds holding MDNA

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
NDSI
Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings's MDNA Position: Q4 2023 in Review

Osaic Holdings sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q4 2023, closing a stake of 22,000 shares — an estimated $6.49K sold.

Osaic Holdings first reported a position in MDNA in Q4 2020 and held it in 12 quarters. The position peaked at $96K in Q1 2022. 3 funds tracked by Wall St. Rank hold MDNA as of Q4 2023.

  • Osaic Holdings reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q4 2023 after selling out during the quarter.
  • Osaic Holdings sold 22,000 Medicenna Therapeutics Corp. Common Shares shares in Q4 2023, an estimated $6.49K.
  • Osaic Holdings first reported a position in Medicenna Therapeutics Corp. Common Shares in Q4 2020 and held it in 12 quarters.
  • Osaic Holdings's Medicenna Therapeutics Corp. Common Shares position peaked at $96K in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q4 2023.

Based on Osaic Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.